Short Communication: Nitazoxanide Inhibits HIV Viral Replication in Monocyte-Derived Macrophages
- 1 February 2015
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 31 (2) , 237-241
Abstract
We document the anti-HIV activity of nitazoxanide (NTZ), the first member of the thiazolide class of antiinfective drugs, originally effective against enteritis caused by Cryptosporidium parvum and Giardia lamblia. NTZ has been administered extensively worldwide, with no severe toxicities associated with its use. Here, we show for the first time that NTZ decreases HIV-1 replication in monocyte-derived macrophages (MDM) if present before or during HIV-1 infection. This NTZ effect is associated with downregulation of HIV-1 receptors CD4 and CCR5, and increasing gene expression of host cell anti-HIV resistance factors APOBEC3A/3G and tetherin. As NTZ is already in clinical use for other conditions, this newly described anti-HIV activity in MDM may facilitate innovative intensification strategies against HIV-1 when combined with current antiretroviral drug regimens.Keywords
This publication has 34 references indexed in Scilit:
- Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA IntegrationThe Journal of Infectious Diseases, 2012
- Systematic identification of synergistic drug pairs targeting HIVNature Biotechnology, 2012
- No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30days course of nitazoxanide monotherapyAntiviral Research, 2011
- Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational LevelJournal of Biological Chemistry, 2009
- Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to CellsCell, 2009
- Antiviral roles of APOBEC proteins against HIV-1 and suppression by VifArchives of Virology, 2009
- APOBEC3 proteins and reverse transcriptionVirus Research, 2008
- The interferon-induced expression of APOBEC3G in human blood–brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous systemVirology, 2007
- Post-transcriptional control of the interferon systemBiochimie, 2007
- The Macrophage in HIV InfectionImmunobiology, 2001